AI readiness in pharma: Getting the foundation right
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
AI readiness in pharma depends on data, not just AI. Read how real‑world data and interoperability enable scalable evidence generation.
A closer look at how RWD, analytics, and AI are reshaping standard of care insights and evidence generation across the drug lifecycle.
BC Platforms in the press: GeneOnline highlights our call to close Asia’s data gap and our role in building secure TREs.
BC Catalyst transforms genomic and real-world data into fast, actionable insights to advance precision medicine at scale.
BC Platforms launches its EHDS-Ready Trusted Research Environment, enabling EU healthcare institutions to meet upcoming EHDS regulations with secure, automated and AI-driven tools.
BC Platforms, Modirum, VEIL.AI and Productivity Leap introduce an AI-enabled reference architecture that automates EHDS2 data discovery, access and secure analysis.